30,000 vaccines allocated to PDLs - DOJ chief | Inquirer News

30,000 vaccines allocated to PDLs – DOJ chief

/ 07:23 PM December 02, 2021

MANILA, Philippines—A total of 30,000 vaccines have been allocated to persons deprived of liberty (PDL) at the Bureau of Corrections (BuCor), Justice Secretary Menardo Guevarra said Thursday.

He said the vaccines would be delivered to the seven penal colonies under BuCor, including the New Bilibid Prison.

ADVERTISEMENT

FEATURED STORIES

“At least 30,000 vaccine doses have been allocated for PDLs under BuCor’s jurisdiction. These vaccines will be farmed out to the various prison facilities of the BuCor for administration,” he said.

The vaccines have been allocated to BuCor following Guevarra’s request to vaccine czar Secretary Carlito Galvez Jr.

In his letter, Guevarra asked that the PDL’s be included in the “Bayanihan Bakuhahan” program of the government.

ADVERTISEMENT

Guevarra said the PDLs, most of which are elderly and sickly are forced to live in cramped, congested quarters, making them vulnerable to COVID-19.

Galvez, in response, said, “We wholeheartedly agree with the Secretary’s assessment [that] the vaccination of PDLs is vital to prevent virus transmission in an overcrowded environment such as prison facilities.”

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: Bucor, COVID-19, Prison, vaccine

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.